Reversing immune suppression in pancreatic cancer could lead to novel therapies

In a unique finding, researchers at Georgetown’s Lombardi Comprehensive Cancer Center discovered that when pancreatic cancer cells send out tiny particles that are packed with certain microRNA molecules, nearby immune cells called macrophages are reprogrammed to help the tumor grow instead of engaging in their regular role of fighting the tumor. This insight from cell and mouse experiments helped the scientists outline a potential way to reverse the process and possibly improve outcomes in pancreatic cancer.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup